Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rxo (RXO) Total Debt (2022 - 2025)

Rxo's Total Debt history spans 4 years, with the latest figure at $404.0 million for Q4 2025.

  • For Q4 2025, Total Debt rose 9.78% year-over-year to $404.0 million; the TTM value through Dec 2025 reached $404.0 million, up 9.78%, while the annual FY2025 figure was $404.0 million, 9.78% up from the prior year.
  • Total Debt reached $404.0 million in Q4 2025 per RXO's latest filing, roughly flat from $403.0 million in the prior quarter.
  • In the past five years, Total Debt ranged from a high of $455.0 million in Q4 2022 to a low of $11.0 million in Q3 2022.
  • Average Total Debt over 4 years is $377.9 million, with a median of $403.0 million recorded in 2025.
  • The largest YoY upside for Total Debt was 4027.27% in 2023 against a maximum downside of 21.1% in 2023.
  • A 4-year view of Total Debt shows it stood at $455.0 million in 2022, then fell by 21.1% to $359.0 million in 2023, then rose by 2.51% to $368.0 million in 2024, then rose by 9.78% to $404.0 million in 2025.
  • Per Business Quant, the three most recent readings for RXO's Total Debt are $404.0 million (Q4 2025), $403.0 million (Q3 2025), and $403.0 million (Q2 2025).